| Code | Description | Claims | Beneficiaries | Total Paid |
| G0378 |
Hospital observation service, per hour |
1,710 |
983 |
$1.12M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
6,135 |
5,891 |
$1.05M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
5,635 |
5,397 |
$1.01M |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
492 |
483 |
$392K |
| 62323 |
|
385 |
369 |
$223K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
2,296 |
2,272 |
$212K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,700 |
1,637 |
$183K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,220 |
1,178 |
$157K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
1,904 |
1,827 |
$131K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
688 |
422 |
$78K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
530 |
512 |
$69K |
| 76642 |
|
1,336 |
1,267 |
$67K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
2,311 |
2,272 |
$54K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
847 |
825 |
$51K |
| T1015 |
Clinic visit/encounter, all-inclusive |
406 |
146 |
$47K |
| 77066 |
Tomosynthesis, mammo |
449 |
444 |
$44K |
| 95886 |
|
541 |
507 |
$35K |
| 77065 |
Tomosynthesis, mammo |
368 |
349 |
$26K |
| 71046 |
Radiologic examination, chest; 2 views |
1,808 |
1,758 |
$23K |
| 36000 |
|
799 |
775 |
$23K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
164 |
54 |
$21K |
| 0001A |
|
433 |
433 |
$20K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
738 |
727 |
$19K |
| 0002A |
|
333 |
333 |
$19K |
| 94729 |
|
632 |
627 |
$19K |
| 76641 |
|
322 |
282 |
$18K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,143 |
1,097 |
$18K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
442 |
428 |
$17K |
| 94726 |
|
612 |
608 |
$16K |
| 76830 |
Ultrasound, transvaginal |
333 |
329 |
$16K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
254 |
250 |
$15K |
| 94060 |
|
674 |
666 |
$15K |
| J1439 |
Injection, ferric carboxymaltose, 1 mg |
19 |
12 |
$15K |
| 97161 |
|
241 |
229 |
$15K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
355 |
347 |
$13K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,325 |
1,012 |
$12K |
| 76770 |
|
257 |
250 |
$12K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
370 |
302 |
$11K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
3,397 |
3,285 |
$11K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
4,854 |
4,014 |
$11K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
3,047 |
2,744 |
$9K |
| 95909 |
|
216 |
212 |
$8K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
165 |
165 |
$8K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
264 |
256 |
$8K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
5,518 |
4,685 |
$8K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
500 |
481 |
$7K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,681 |
1,554 |
$7K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
93 |
90 |
$7K |
| 71250 |
|
122 |
120 |
$7K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
481 |
433 |
$6K |
| 73630 |
|
417 |
363 |
$5K |
| 76536 |
|
93 |
88 |
$4K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
94 |
90 |
$4K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
27 |
27 |
$4K |
| 70486 |
|
150 |
144 |
$4K |
| 72100 |
|
173 |
171 |
$4K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
465 |
454 |
$4K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
74 |
72 |
$4K |
| 97803 |
|
82 |
82 |
$4K |
| 71045 |
Radiologic examination, chest; single view |
1,137 |
1,084 |
$3K |
| 0004A |
|
63 |
63 |
$3K |
| C1769 |
Guide wire |
137 |
132 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
773 |
602 |
$3K |
| 77336 |
|
66 |
28 |
$3K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
194 |
185 |
$3K |
| 84484 |
|
1,499 |
1,267 |
$3K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
14 |
14 |
$3K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
210 |
203 |
$3K |
| 93971 |
|
72 |
71 |
$3K |
| A9585 |
Injection, gadobutrol, 0.1 ml |
161 |
156 |
$3K |
| 77080 |
|
53 |
53 |
$3K |
| 73030 |
|
218 |
198 |
$2K |
| 73610 |
|
207 |
179 |
$2K |
| 77061 |
|
78 |
76 |
$2K |
| 85730 |
|
1,169 |
1,100 |
$2K |
| 80053 |
Comprehensive metabolic panel |
695 |
574 |
$2K |
| 0012A |
|
31 |
31 |
$2K |
| 95911 |
|
28 |
28 |
$2K |
| 76000 |
|
217 |
210 |
$2K |
| 73564 |
|
198 |
172 |
$2K |
| 73130 |
|
191 |
160 |
$2K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
12 |
12 |
$2K |
| 80076 |
|
1,092 |
1,015 |
$1K |
| 0003A |
|
19 |
19 |
$1K |
| 85610 |
|
1,302 |
1,232 |
$1K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
27 |
27 |
$1K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
275 |
264 |
$962.27 |
| 85027 |
|
561 |
473 |
$904.09 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
175 |
168 |
$898.83 |
| 0011A |
|
36 |
36 |
$890.96 |
| 90715 |
|
180 |
176 |
$795.99 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
349 |
315 |
$787.25 |
| 84443 |
Thyroid stimulating hormone (TSH) |
327 |
301 |
$782.81 |
| 77062 |
|
30 |
30 |
$762.28 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
502 |
488 |
$751.99 |
| 83735 |
|
1,022 |
837 |
$740.70 |
| 86900 |
|
482 |
463 |
$720.02 |
| 97802 |
|
12 |
12 |
$714.82 |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
34 |
25 |
$714.75 |
| 86850 |
|
436 |
424 |
$707.80 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
38 |
36 |
$668.38 |
| 83690 |
|
893 |
831 |
$658.03 |
| 76376 |
|
31 |
31 |
$654.16 |
| 76801 |
|
13 |
12 |
$613.57 |
| J2704 |
Injection, propofol, 10 mg |
2,223 |
2,130 |
$597.24 |
| 93975 |
|
14 |
14 |
$585.69 |
| 80320 |
|
176 |
171 |
$566.37 |
| 82805 |
|
54 |
51 |
$543.64 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
116 |
111 |
$510.78 |
| 86901 |
|
458 |
443 |
$442.22 |
| 83880 |
|
115 |
110 |
$440.71 |
| 73562 |
|
18 |
12 |
$399.86 |
| 72040 |
|
24 |
24 |
$379.35 |
| 84702 |
|
108 |
105 |
$363.50 |
| 81003 |
|
781 |
751 |
$339.48 |
| J3490 |
Unclassified drugs |
3,153 |
1,989 |
$328.86 |
| A9270 |
Non-covered item or service |
7,049 |
1,985 |
$318.75 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
71 |
43 |
$311.89 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
966 |
941 |
$306.14 |
| 83605 |
|
316 |
291 |
$292.36 |
| 85379 |
|
195 |
185 |
$287.03 |
| 96367 |
|
23 |
13 |
$254.85 |
| 84703 |
|
125 |
123 |
$245.42 |
| 80329 |
|
92 |
88 |
$221.08 |
| 73110 |
|
30 |
24 |
$209.59 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
143 |
135 |
$203.06 |
| 81001 |
|
471 |
451 |
$181.71 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
883 |
701 |
$176.19 |
| 82962 |
|
557 |
382 |
$165.03 |
| 36415 |
Collection of venous blood by venipuncture |
976 |
750 |
$162.18 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,141 |
1,561 |
$161.30 |
| 99152 |
|
78 |
75 |
$159.90 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
100 |
97 |
$150.73 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
618 |
549 |
$146.74 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
2,853 |
2,377 |
$137.92 |
| 87088 |
|
136 |
132 |
$120.86 |
| 73502 |
|
14 |
14 |
$113.37 |
| 73590 |
|
12 |
12 |
$99.30 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
801 |
655 |
$78.29 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
115 |
110 |
$77.29 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,904 |
2,572 |
$71.92 |
| J1644 |
Injection, heparin sodium, per 1000 units |
716 |
431 |
$69.94 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
237 |
159 |
$67.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
3,303 |
2,744 |
$51.92 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
650 |
504 |
$47.43 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,918 |
2,536 |
$46.72 |
| 82550 |
|
54 |
48 |
$41.36 |
| 84100 |
|
127 |
93 |
$37.81 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
2,269 |
2,148 |
$37.09 |
| J1815 |
Injection, insulin, per 5 units |
488 |
211 |
$29.34 |
| 87040 |
|
12 |
12 |
$28.00 |
| 99153 |
Mod sedat endo service >5yrs |
17 |
15 |
$24.32 |
| 80061 |
Lipid panel |
43 |
41 |
$21.85 |
| 88307 |
|
13 |
12 |
$18.63 |
| J1956 |
Injection, levofloxacin, 250 mg |
31 |
27 |
$7.10 |
| 81025 |
|
26 |
26 |
$6.89 |
| S0028 |
Injection, famotidine, 20 mg |
28 |
26 |
$4.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
235 |
203 |
$3.78 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
80 |
76 |
$3.39 |
| J2060 |
Injection, lorazepam, 2 mg |
52 |
43 |
$2.84 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
104 |
80 |
$0.60 |
| 91300 |
|
181 |
167 |
$0.08 |
| 96376 |
|
350 |
274 |
$0.00 |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
662 |
400 |
$0.00 |
| 88342 |
|
12 |
12 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
117 |
102 |
$0.00 |
| 86140 |
|
16 |
12 |
$0.00 |
| J7999 |
Compounded drug, not otherwise classified |
112 |
90 |
$0.00 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
13 |
12 |
$0.00 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
46 |
45 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
348 |
243 |
$0.00 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
617 |
374 |
$0.00 |
| J1756 |
Injection, iron sucrose, 1 mg |
956 |
425 |
$0.00 |
| 87186 |
|
48 |
46 |
$0.00 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
15 |
13 |
$0.00 |
| J1453 |
Injection, fosaprepitant, 1 mg |
53 |
39 |
$0.00 |
| 87631 |
|
58 |
58 |
$0.00 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
220 |
192 |
$0.00 |
| C1758 |
Catheter, ureteral |
12 |
12 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
15 |
12 |
$0.00 |
| J9271 |
Injection, pembrolizumab, 1 mg |
82 |
73 |
$0.00 |
| J2004 |
Injection, lidocaine hcl with epinephrine, 1 mg |
38 |
37 |
$0.00 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
28 |
27 |
$0.00 |